$6.97
-0.09-1.27%
À la fermeture: -
$6.98
0.010.14%
Pré-commercialisation: 7:48 AM EDT
Comments
Loading...
Orientation et prévision
Novavax publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/06/2025 | NVAX | Novavax | FY | 2025 | — | — | — | $1.04B | $1.06B | $1.06B | |
08/06/2025 | NVAX | Novavax | FY | 2025 | — | — | — | $1.00B | $1.05B | $1.03B | |
05/08/2025 | NVAX | Novavax | FY | 2025 | — | — | — | $975.00M | $1.02B | — | |
01/13/2025 | NVAX | Novavax | FY | 2024 | — | — | — | $650.00M | $700.00M | $724.08M | |
11/12/2024 | NVAX | Novavax | FY | 2024 | — | — | — | $650.00M | $700.00M | $761.46M | |
08/08/2024 | NVAX | Novavax | FY | 2024 | — | — | — | $700.00M | $800.00M | $936.38M | |
05/10/2024 | NVAX | Novavax | FY | 2024 | — | — | — | $400.00M | $600.00M | $845.49M | |
02/28/2024 | NVAX | Novavax | Q1 | 2024 | — | — | — | $100.00M | $100.00M | $292.33M | |
02/28/2024 | NVAX | Novavax | FY | 2024 | — | — | — | $800.00M | $1.00B | $969.56M | |
11/09/2023 | NVAX | Novavax | FY | 2023 | — | — | — | $900.00M | $1.10B | $1.35B | |
11/09/2023 | NVAX | Novavax | Q1 | 2024 | — | — | — | $300.00M | $300.00M | $648.29M | |
08/08/2023 | NVAX | Novavax | FY | 2023 | — | — | — | $1.30B | $1.50B | $1.44B | |
05/09/2023 | NVAX | Novavax | FY | 2023 | — | — | — | $1.40B | $1.60B | $831.60M | |
12/14/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $2.00B | $2.00B | $2.01B | |
11/08/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $2.00B | $2.00B | $2.04B | |
08/08/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $2.00B | $2.30B | $4.27B | |
05/09/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $4.00B | $5.00B | $4.49B | |
02/28/2022 | NVAX | Novavax | FY | 2022 | — | — | — | $4.00B | $5.00B | $4.70B |
FAQ
Quelles sont les dernières directives pour Novavax (NVAX) ?
Il n'y a eu aucune orientation spécifique sur les ventes ou les bénéfices rapportée pour Novavax ces derniers mois.
Parcourir guidance et prévisions sur toutes les actions.